Cas No.: | 858668-07-2 |
Chemical Name: | 1-[[(2R,4aS,5R,10bS)-5-phenyl-9-(trifluoromethyl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-2-yl]methyl]-3-[2-(dimethylamino)ethyl]urea |
Synonyms: | EMD534085; EMD-534085; EMD 534085. |
SMILES: | O=C(NC[C@@H]1OC(C(C=C(C(F)(F)F)C=C2)=C2NC3C4=CC=CC=C4)([H])C3([H])CC1)NCCN(C)C |
Formula: | C25H31F3N4O2 |
M.Wt: | 476.53445 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | EMD 534085, a potent, reversible Eg5 inhibitor, demonstrated significant preclinical antitumor activityFor the detailed information of EMD534085, the solubility of EMD534085 in water, the solubility of EMD534085 in DMSO, the solubility of EMD534085 in PBS buffer, the animal experiment (test) of EMD534085, the cell expriment (test) of EMD534085, the in vivo, in vitro and clinical trial test of EMD534085, the EC50, IC50,and Affinity of EMD534085, Please contact DC Chemicals. |